[1]
“ROLE OF HORMONE RECEPTORS AND HER2 IMMUNOHISTOCHEMISTRY IN PREDICTING RESPONSE TONEOADJUVANT CHEMOTHERAPY IN BREAST CANCER”, IJARR, vol. 1, no. 11, pp. 22–26, Nov. 2016, Accessed: Jul. 16, 2026. [Online]. Available: https://www.ijarr.org/index.php/ijarr/article/view/717